Medicare Enrolled
Dr. Benito Marranzini, M.D.
Endocrinology · El Paso, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Marranzini from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Marranzini?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Marranzini
Dr. Benito Marranzini is an endocrinology specialist in El Paso, TX, with 21 years of NPI registration. Based on federal Medicare data, Dr. Marranzini performed 798 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Marranzini received a total of $28,813 from 67 pharmaceutical and/or device companies across 1751 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Marranzini is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 49% volume in TX
$28,813 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗798
Medicare services
Top 49% in TX for endocrinology
Not available
Unique patients (not deduplicated)
$89
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
603 | $84 | $263 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
116 | $121 | $346 |
| New patient office visit, complex (60-74 min) | 29 | $150 | $496 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
20 | $56 | $170 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
17 | $26 | $90 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
13 | $9 | $40 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$28,813
Total received (2018-2024)
Avg $4,116/year across 7 years
Top 18% in TX for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
67
Companies
1,751
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,330
2023
$4,049
2022
$5,126
2021
$3,942
2020
$2,884
2019
$3,723
2018
$3,758
Payments by company (2024)
Dexcom, Inc.
$530
Lilly USA, LLC
$528
Novo Nordisk Inc
$424
Amgen Inc.
$390
Insulet Corporation
$331
Bayer Healthcare Pharmaceuticals Inc.
$323
Corcept Therapeutics
$314
ABBVIE INC.
$266
Boehringer Ingelheim Pharmaceuticals, Inc.
$208
Regeneron Healthcare Solutions, Inc.
$208
Novartis Pharmaceuticals Corporation
$189
Tandem Diabetes Care, Inc.
$180
RECORDATI_RARE_DISEASES_INC.
$174
Antares Pharma, Inc.
$155
Abbott Laboratories
$155
Mannkind Corporation
$139
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$116
SANOFI-AVENTIS U.S. LLC
$108
Xeris Pharmaceuticals, Inc.
$91
Medtronic, Inc.
$85
Radius Health, Inc.
$76
BETA BIONICS, INC.
$66
Alexion Pharmaceuticals, Inc.
$48
AstraZeneca Pharmaceuticals LP
$47
Madrigal Pharmaceuticals
$41
Esperion Therapeutics, Inc.
$36
Ascendis Pharma Inc
$30
Astellas Pharma US Inc
$19
Ultragenyx Pharmaceutical Inc.
$19
Merck Sharp & Dohme LLC
$18
PFIZER INC.
$17
Top 3 companies account for 27.8% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$3,523
Novo Nordisk Inc
$3,423
Lilly USA, LLC
$2,005
Abbott Laboratories
$1,520
SANOFI-AVENTIS U.S. LLC
$1,501
AstraZeneca Pharmaceuticals LP
$1,410
Dexcom, Inc.
$1,372
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,287
Corcept Therapeutics
$982
Insulet Corporation
$932
RECORDATI_RARE_DISEASES_INC.
$931
Radius Health, Inc.
$789
Janssen Pharmaceuticals, Inc
$687
Bayer Healthcare Pharmaceuticals Inc.
$660
Amarin Pharma Inc.
$591
ABBVIE INC.
$512
Medtronic, Inc.
$430
Bayer HealthCare Pharmaceuticals Inc.
$408
Antares Pharma, Inc.
$383
Novartis Pharmaceuticals Corporation
$367
Tandem Diabetes Care, Inc.
$333
Regeneron Healthcare Solutions, Inc.
$332
Horizon Therapeutics plc
$315
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$307
Merck Sharp & Dohme Corporation
$296
AbbVie Inc.
$284
EUSA Pharma (US) LLC
$252
Biohaven Pharmaceuticals, Inc.
$244
DEXCOM, INC.
$237
Xeris Pharmaceuticals, Inc.
$204
Mannkind Corporation
$185
Medtronic MiniMed, Inc.
$174
AbbVie, Inc.
$163
PFIZER INC.
$135
Esperion Therapeutics, Inc.
$130
Biohaven Pharmaceutical Holding Company Ltd.
$125
Ultragenyx Pharmaceutical Inc.
$110
Inspire Medical Systems, Inc.
$109
Kowa Pharmaceuticals America, Inc.
$101
Alexion Pharmaceuticals, Inc.
$90
Vifor Pharma, Inc.
$87
EISAI INC.
$79
Kyowa Kirin, Inc.
$72
ARBOR PHARMACEUTICALS, INC.
$71
Takeda Pharmaceuticals U.S.A., Inc.
$68
Ascendis Pharma Inc
$68
BETA BIONICS, INC.
$66
Amryt Pharma Holdings Ltd
$54
Merck Sharp & Dohme LLC
$47
Madrigal Pharmaceuticals
$41
Allergan Inc.
$34
Supernus Pharmaceuticals, Inc.
$29
IBSA Pharma Inc.
$29
Ipsen Biopharmaceuticals, Inc
$27
Becton, Dickinson and Company
$26
OPKO Pharmaceuticals, LLC
$23
GlaxoSmithKline, LLC.
$20
Astellas Pharma US Inc
$19
Allergan, Inc.
$18
Ironwood Pharmaceuticals, Inc
$16
Shire North American Group Inc
$14
Avion Pharmaceuticals
$14
Strongbridge US INC.
$13
Nalpropion Pharmaceuticals LLC
$12
Eisai Inc.
$12
Aegerion Pharmaceuticals, Inc.
$11
CeQur Corporation
$6
Top 3 companies account for 31.1% of all-time payments
Associated products mentioned in payments ›
AFREZZA · Aimovig · Amitiza · Androgel · BAQSIMI · BASAGLAR · BD Nano · BELSOMRA · BYSTOLIC · Balcoltra · Belviq · CHANTIX · COMIRNATY · CONTRAVE · CeQur Simplicity · Corlanor · Crysvita · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · DIABETES - DISEASE · Dexcom CGM · Dexcom G6 Transmitter · Dexilant · ENTRESTO · EVENITY · EVKEEZA · Edarbi · Edarbyclor · FARXIGA · FORTEO · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · GARDASIL · GLYXAMBI · GUARDIAN SENSOR (3) · GVOKE HYPOPEN · GVOKE PFS · HUMALOG · HUMULIN · Horizant · ICD Leads · INCRELEX · INPEN SMART INSULIN DELIVERY SYSTEM · INSPIRE · INTELLIS ADAPTIVESTIM · INVOKANA · ISTURISA · InPen · JANUVIA · JARDIANCE · Kerendia · Korlym · LEQVIO · LINZESS · LIVALO · LOKELMA · Linzess · Livalo · MACRILEN · MINIMED 770G · MINIMED 780G · MOUNJARO · MYALEPT · MYCAPSSA · Minimed 670G System · Minimed 770G System · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NOCDURNA · NURTEC ODT · OTREXUP · Omnipod · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PREVNAR 13 · Prolia · QULIPTA · Quadra Assura CRT Defibrillator · RECORLEV · RESMETIROM · RYBELSUS · Rayaldee · Repatha · Rybelsus · SHINGRIX · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · STEGLATRO · SYNTHROID · Saxenda · Sogroya · Sylvant · Synthroid · TEFLARO · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tresiba · Trintellix · Tymlos · UBRELVY · Vascepa · Veltassa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · XYOSTED · ZEPBOUND · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Endocrinologists in nearby ZIP areas
14
County median income
$58,859
Nearest hospital to ZIP centroid (approximate)
UNIVERSITY MEDICAL CENTER OF EL PASO
5.6 mi
5.6 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Marranzini is a clinical cardiology specialist, with moderate Medicare volume, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Marranzini experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Marranzini performed 603 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Marranzini receive payments from pharmaceutical companies?
Yes. Dr. Marranzini received a total of $28,813 from 67 companies across 1,751 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Marranzini's costs compare to other endocrinologists in El Paso?
Dr. Marranzini's average Medicare payment per service is $89. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Marranzini) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in El Paso
Browse endocrinologists in El Paso ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in TX
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in TX
Which TX endocrinologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology